Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[RNAi and neurological disease].

Takanori Yokota1

  • 1Department of Neurology and Neurological Science, Tokyo Medical and Dental University.

Rinsho Shinkeigaku = Clinical Neurology
|February 2, 2006
PubMed
Summary

Small interfering RNA (siRNA) therapy shows promise for autosomal dominant neurodegenerative diseases. This gene therapy approach successfully halted disease progression in a mouse model of amyotrophic lateral sclerosis (ALS).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative Measurement of Extracellular Vesicle-Sized Particles in Blood Plasma by Laser Diffraction Without an Extraction Process: A Proof-of-Concept Study in Atrial Fibrillation.

Journal of arrhythmia·2026
Same author

Detection of Anti-Aquaporin-4 Antibodies in a Patient With Glioma: A Case Report.

The Neurohospitalist·2026
Same author

Long-term cerebral atrophy and cognitive function in patients recovering from progressive multifocal leukoencephalopathy: two case reports.

BMC neurology·2026
Same author

Rational Design of a Multivalent RNA Combining Structural Motifs Tailored to Multiple Domains of Fused in Sarcoma for Potent Inhibition of Aggregation.

Chembiochem : a European journal of chemical biology·2026
Same author

Quantitative evaluation of iron chelator effects on central motor and sensory tracts in superficial siderosis.

Frontiers in neurology·2026
Same author

Two Cases of CLIPPERS-like Syndrome Sharing a Hypomorphic UNC13D Variant.

Journal of clinical immunology·2026

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Autosomal dominant neurodegenerative diseases, including ALS, Alzheimer's, Parkinson's, and prion diseases, are often caused by a 'gain of toxic function' mutation in specific genes.
  • Developing therapies to specifically eliminate these aberrant proteins is a rational therapeutic strategy for these conditions.

Purpose of the Study:

  • To investigate the potential of small interfering RNA (siRNA) as a therapeutic tool for autosomal dominant neurodegenerative diseases.
  • To evaluate the efficacy of mutant-allele-specific gene silencing using siRNA in a mouse model of familial ALS.

Main Methods:

  • Developed a transgenic (Tg) mouse expressing modified small interfering RNA (siRNA) targeting SOD1.
  • Crossed the anti-SOD1 siRNA Tg mouse with a SOD1(G93A) Tg mouse, a model for amyotrophic lateral sclerosis (ALS).
  • Assessed the impact of siRNA expression on disease development and mutant SOD1 levels.

Main Results:

  • The developed siRNA effectively inhibited the expression of the mutant G93A SOD1 protein.
  • The transgenic siRNA approach significantly halted the progression of the disease in the ALS mouse model.
  • Demonstrated mutant-allele-specific gene silencing in vivo.

Conclusions:

  • Small interfering RNA (siRNA) represents a feasible gene therapy strategy for neurodegenerative diseases with autosomal dominant inheritance.
  • This approach holds potential for treating conditions like familial ALS by specifically targeting and silencing disease-causing mutant genes.

Related Experiment Videos